← Insider buys

TOI

The Oncology Institute, Inc. · Healthcare

Insiders bought $609K of The Oncology Institute, Inc. in the last 12 months

1 insider bought on 6 days.

$609KBought, 12 mo
$662KSold, 12 mo
$512.9MMarket cap

TOI over the last year

Insider buy filed (6 days)

Largest buyers, last 12 months

TOI after insider buys

3 months after each buy, from the first price a copier could get.

+63.1%Average
+56.5 ptsVs S&P 500
8 of 9Higher

9 buys since 2021 with 3 months of prices.

Every filing

46 insider filings since 2021, newest first

TOIBuy

Jorey Chernett · 10% owner

$95K+0.2%Jul 22
TOISell

Yale Podnos · Chief Medical Officer

$150K−8.3%Jul 17
TOIBuy

Jorey Chernett · 10% owner

$88K+0.1%Jul 13
TOIBuy

Jorey Chernett · 10% owner

$90K+0.2%Jun 24
TOISell

Yale Podnos · Chief Medical Officer

$126K−8.3%Jun 9
TOIBuy

Jorey Chernett · 10% owner

$57K+0.1%Jun 5
TOIBuy

Jorey Chernett · 10% owner

$157K+0.4%May 21
TOIBuy

Jorey Chernett · 10% owner

$123K+0.3%May 20
TOISell

Mohit Kaushal · Director

$335K−36.0%Apr 16
TOISell

Brad Hively · Director

$50K−2.0%Dec 16
TOIBuy

Brad Hively · Director

$47K+7.0%Apr 28
TOIBuy

Mark L Pacala · Director

$94K+67.0%Mar 28
TOIBuy

Karen Marie Johnson · Director

$38K+22.0%Mar 28
TOIBuy

Richard A Barasch · Director

$1.4M+326.0%Mar 28
TOIBuy

Brad Hively · Director

$50K+82.0%Dec 2
TOISell

Havencrest Healthcare Partners, L.P. · 10% owner

$97KJan 26
TOISell

Havencrest Healthcare Partners, L.P. · 10% owner

$59KJan 23
TOIBuy

Mihir Shah · CFO

$127K+44.0%Dec 18
TOISell

Brad Hively · Director

$56K−3.0%Nov 21
TOISell

Brad Hively · Director

$119K−6.0%Nov 15
TOIBuy

Richard A Barasch · Director

$27K+24.0%Mar 21
TOISell

Mohit Kaushal · Director

$34K−39.0%Nov 15
TOISell

Havencrest Healthcare Partners, L.P. · 10% owner

$851K−3.0%Nov 15
TOISell

Havencrest Healthcare Partners, L.P. · 10% owner

$517K−1.0%Nov 10
TOISell

Havencrest Healthcare Partners, L.P. · 10% owner

$396K−1.0%Nov 7
TOISell

Havencrest Healthcare Partners, L.P. · 10% owner

$641K−1.0%Nov 2
TOISell

Havencrest Healthcare Partners, L.P. · 10% owner

$701K−1.0%Oct 28
TOISell

Havencrest Healthcare Partners, L.P. · 10% owner

$401K−1.0%Oct 25
TOISell

Havencrest Healthcare Partners, L.P. · 10% owner

$196KOct 20
TOISell

Havencrest Healthcare Partners, L.P. · 10% owner

$200KOct 17
TOISell

Havencrest Healthcare Partners, L.P. · 10% owner

$277KOct 12
TOISell

Havencrest Healthcare Partners, L.P. · 10% owner

$284KOct 7
TOISell

Havencrest Healthcare Partners, L.P. · 10% owner

$244KOct 4
TOISell

Havencrest Healthcare Partners, L.P. · 10% owner

$223KSep 29
TOISell

Havencrest Healthcare Partners, L.P. · 10% owner

$111KSep 26
TOISell

Havencrest Healthcare Partners, L.P. · 10% owner

$1.3M−2.0%Sep 19
TOISell

Havencrest Healthcare Partners, L.P. · 10% owner

$676K−1.0%Sep 14
TOISell

Havencrest Healthcare Partners, L.P. · 10% owner

$523K−1.0%Sep 9
TOISell

Havencrest Healthcare Partners, L.P. · 10% owner

$944K−1.0%Sep 6
TOISell

Havencrest Healthcare Partners, L.P. · 10% owner

$489K−1.0%Aug 31
TOISell

Havencrest Healthcare Partners, L.P. · 10% owner

$397KAug 26
TOISell

Havencrest Healthcare Partners, L.P. · 10% owner

$620K−1.0%Aug 23
TOISell

Havencrest Healthcare Partners, L.P. · 10% owner

$324KAug 16
TOISell

Richy Agajanian · 10% owner

$9.6M−86.0%May 13
TOIBuy

Richard A Barasch · Director

$35K+5.0%Nov 24
TOIBuy

Richard A Barasch · Director

$32K+6.0%Nov 24
About The Oncology Institute, Inc.

The Oncology Institute, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company offers physician services, in-house infusion, in-house specialty pharmacy, clinical trials, radiation therapy, and outpatient blood product transfusion services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance and support services. It also manages clinical trials and palliative care programs; operates combined community clinics and infusion suites; and operates a specialty pharmacy that includes both in-office and mail-order dispensing for complementary oral and self-injectable medications taken by patients concurrent with their in-office cancer therapies. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.

Filings come from SEC EDGAR and prices from daily closes. Not investment advice.